Invention Grant
- Patent Title: Small molecule agonists and antagonists of NR2F6 activity
-
Application No.: US16008526Application Date: 2018-06-14
-
Publication No.: US11377442B2Publication Date: 2022-07-05
- Inventor: Harry M. Lander , David R. Koos
- Applicant: ZANDER THERAPEUTICS, INC.
- Applicant Address: US CA La Mesa
- Assignee: ZANDER THERAPEUTICS, INC.
- Current Assignee: ZANDER THERAPEUTICS, INC.
- Current Assignee Address: US CA La Mesa
- Agency: Baumgartner Patent Law
- Agent Marc Baumgartner
- Main IPC: A61K31/381
- IPC: A61K31/381 ; A61K31/4025 ; A61K31/4436 ; C07D409/14 ; C07D409/04 ; C07D333/48 ; A61K35/17 ; A61K31/366 ; A61K31/4245 ; A61K31/4706 ; A61K31/496 ; A61K31/506 ; A61K31/5377 ; A61P35/00
Abstract:
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein.
Public/Granted literature
- US20180346456A1 SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY Public/Granted day:2018-12-06
Information query
